These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol. Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R; Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394 [TBL] [Abstract][Full Text] [Related]
25. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis. Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328 [TBL] [Abstract][Full Text] [Related]
26. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Bonifácio LP; Ramacciotti E; Agati LB; Vilar FC; Silva ACTD; Louzada Júnior P; Fonseca BALD; Souza HCC; Oliveira CCC; Aguiar VCR; Quadros CAA; Dusilek C; Itinose K; Risson R; Ferreira LRR; Lopes RD; Kallas EG; Bellissimo-Rodrigues F Rev Soc Bras Med Trop; 2023; 56():e0565. PubMed ID: 37075454 [TBL] [Abstract][Full Text] [Related]
28. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial. Dalili N; Kashefizadeh A; Nafar M; Poorrezagholi F; Firouzan A; Samadian F; Samavat S; Ziaie S; Fatemizadeh S Trials; 2020 Jun; 21(1):489. PubMed ID: 32503620 [TBL] [Abstract][Full Text] [Related]
29. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial. Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A; Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496 [TBL] [Abstract][Full Text] [Related]
30. The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials. Kow CS; Lee LH; Ramachandram DS; Hasan SS; Ming LC; Goh HP Immun Inflamm Dis; 2022 Feb; 10(2):255-264. PubMed ID: 34970856 [TBL] [Abstract][Full Text] [Related]
31. COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review. Nas K; Eryilmaz N; Geyik MF; Altaş A Rheumatol Int; 2021 Apr; 41(4):811-817. PubMed ID: 33611657 [TBL] [Abstract][Full Text] [Related]
32. Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial. Perricone C; Scarsi M; Brucato A; Pisano P; Pigatto E; Becattini C; Cingolani A; Tiso F; Prota R; Tomasoni LR; Cutolo M; Tardella M; Rozza D; Zerbino C; Andreoni M; Poletti V; Bartoloni E; Gerli R; Eur J Intern Med; 2023 Jan; 107():30-36. PubMed ID: 36396522 [TBL] [Abstract][Full Text] [Related]
33. Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression. Nawangsih EN; Kusmala YY; Rakhmat II; Handayani DR; Juliastuti H; Wibowo A; Lim MA; Pranata R Int Immunopharmacol; 2021 Jul; 96():107723. PubMed ID: 34162130 [TBL] [Abstract][Full Text] [Related]
34. Antibiotics for the treatment of COVID-19. Popp M; Stegemann M; Riemer M; Metzendorf MI; Romero CS; Mikolajewska A; Kranke P; Meybohm P; Skoetz N; Weibel S Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015025. PubMed ID: 34679203 [TBL] [Abstract][Full Text] [Related]
35. The role of colchicine in the management of COVID-19: a Meta-analysis. Elshiwy K; Amin GEE; Farres MN; Samir R; Allam MF BMC Pulm Med; 2024 Apr; 24(1):190. PubMed ID: 38641775 [TBL] [Abstract][Full Text] [Related]
36. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state. Vitiello A; Ferrara F Respir Med; 2021 Mar; 178():106322. PubMed ID: 33550151 [TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
38. Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Hariyanto TI; Halim DA; Jodhinata C; Yanto TA; Kurniawan A Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):823-830. PubMed ID: 33719081 [TBL] [Abstract][Full Text] [Related]
39. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Cotter A; Wallace D; McCarthy C; Feeney E; O'Neill L; Stack J; McCarthy G; Hussain R; Alvarez Barco E; Doran P; Mallon P Trials; 2020 Sep; 21(1):758. PubMed ID: 32883328 [TBL] [Abstract][Full Text] [Related]